top of page

Alcohol Treatment Without AA: A Modern Medical Approach to Reducing or Eliminating Alcohol Use for Weight Loss

A Physician-Led Alternative to Traditional Abstinence-Only Recovery Utilizing Medications To Reduce Alcohol Use Helping with Weight Loss


For decades, Alcoholics Anonymous (AA) and 12-step programs have been the default recovery path for those struggling with alcohol use. But for many, these programs simply don’t fit. Whether it’s the spiritual undertone, the strict requirement of complete abstinence, the shunning of modern medication therapy, or the group format, AA doesn’t work for everyone.


Dr. Paul Kolodzik and his team offer a science-based, physician-supervised alternative: medication-assisted treatment (MAT) for alcohol use disorder, including naltrexone, the Sinclair Method, and cutting-edge GLP-1 medications.These therapies help patients in Ohio and Indiana reduce or eliminate their alcohol consumption—without daily meetings or complete abstinence unless they choose it.


The Sinclair Method and Naltrexone: Retraining the Brain

The Sinclair Method (TSM) is a proven medical approach that uses naltrexone, an FDA-approved medication, to reduce cravings and drinking behavior over time. Patients take naltrexone before drinking, which blocks the brain’s reinforcement of alcohol’s pleasurable effects. Over time, this leads to less desire to drink, less consumption, and—in many cases—eventual elimination of alcohol use altogether.

This method is ideal for patients who want:

  • A private, structured medical approach

  • To moderate alcohol use or eventually eliminate it

  • A treatment option outside of AA

  • Treatment that can lead to better metabolic health and weight loss


Sad person beside wine bottle and glass, against prescription background. Text: Alcohol Treatment Without AA. Mood is contemplative.
Alcohol treatment without AA

GLP-1 Medications: A New Frontier in Alcohol Reduction

Originally developed for diabetes and weight loss, GLP-1 medications have shown remarkable promise in reducing alcohol cravings and consumption. Early studies and clinical experience suggest that GLP-1s affect the reward centers in the brain, helping patients naturally lose interest in alcohol—without white-knuckling or deprivation.

When appropriate, on an individualized patient bases, we incorporate GLP-1 medications into our alcohol recovery protocols, especially for patients who:

  • Struggle with strong cravings

  • Have coexisting weight or metabolic health concerns

  • Prefer a modern, research-based medical solution


Learn more about alcohol disorders and how to treat them with new, innovative medications and technology at cgm-doctor.com. To begin a GLP-1 conversation, reach out to metabolicmds.com where Dr. Paul Kolodzik and his team can work with patients in Ohio, Indiana, Florida, and Arizona.

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page